Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

ClinicalTrials.gov ID: NCT02608450

Public ClinicalTrials.gov record NCT02608450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to determine the safety and efficacy of CB-03-01 cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.

Study identification

NCT ID
NCT02608450
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cassiopea SpA
Industry
Enrollment
708 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 20, 2016
Primary completion
Apr 10, 2018
Completion
Apr 10, 2018
Last update posted
Nov 19, 2020

2016 – 2018

United States locations

U.S. sites
44
U.S. states
18
U.S. cities
37
Facility City State ZIP Site status
Gary M. Petrus, MD PA Little Rock Arkansas 72205
Center For Dermatology Clinical Research, Inc. Fremont California 94538
Vitiligo & Pigmentation Institute of Southern California Los Angeles California 90036
San Diego Sports Medicine and Family Health Center San Diego California 92120
Rady Childrens Hospital, Pediatric and Adolescent Dermatology San Diego California 92123
Southern California Dermatology Santa Ana California 92701
Clinical Science Institute Santa Monica California 90404
Memorial Research Medical Clinic dba / Orange County Research Center Tustin California 92780
Horizons Clinical Research Center, LLC Denver Colorado 80220
Site 0190 Boca Raton Florida 33434
Study Protocol, Inc. Boynton Beach Florida 33437
Site 0196 Miami Florida 33125
Site 0197 Miami Florida 33126
Site 0198 Miami Florida 33135
Site 0199 Miami Florida 33145
Site 0191 Miami Florida 33172
Site 0192 Miami Florida 33172
Site 0195 Miami Florida 33176
Tory Sullivan, M.D., P.A. North Miami Beach Florida 33162
Meridien Research St. Petersburg Florida 33709
MOORE Clinical Research, Inc. Tampa Florida 33609
MedaPhase, Inc. Newnan Georgia 30263
Site 0152 Carmel Indiana 46032
The Indiana Clinical Trials Center Plainfield Indiana 46168
Henry Ford Health System Detroit Michigan 48202
MediSearch Clinical Trials Saint Joseph Missouri 64506
The Center for Dermatology, Cosmetic & Laser Surgery Mount Kisco New York 10549
DermResearch Center of New York, Inc. Stony Brook New York 11790
Wake Research Associates Raleigh North Carolina 27612
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
Oregon Dermatology and Research Center Portland Oregon 97210
The Pennsylvania State University and the Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Omega Medical Research Warwick Rhode Island 02886
Greenville Dermatology, LLC Greenville South Carolina 29607
International Clinical Research - Tennessee LLC Murfreesboro Tennessee 37130
Tennessee Clinical Research Center Nashville Tennessee 37215
Westlake Dermatology Clinical Research Center Austin Texas 78746
Bellaire Dermatology Associates Bellaire Texas 77401
J&S Studies, Inc. College Station Texas 77845
The University of Texas Health Science Center at Houston Houston Texas 77030
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660
Clinical Research Associates of Tidewater, Inc. Norfolk Virginia 23507
Dermatology Associates Seattle Washington 98101
Premier Clinical Research Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02608450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02608450 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →